Literature DB >> 1873370

Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders.

L A Abel1, L Friedman, J Jesberger, A Malki, H Y Meltzer.   

Abstract

The smooth pursuit responses to 5 degrees and 20 degrees/sec constant-velocity stimuli were recorded from 23 patients with schizophrenia, 16 affective disorder patients, and 21 normals using low-noise infrared oculography. Pursuit gain, catch-up saccade (CUS) rate and amplitude, and their interrelationships were examined. Gain in the schizophrenic patients was reduced only at 20 degrees/sec, but for both patient groups, CUS rate at 5 degrees/sec was significantly lower than in normals. Using CUS rate at 20 degrees/sec, the patient groups could be distinguished from each other (the rate for schizophrenic patients being highest, and the rate for affectives the lowest) but neither differed significantly from normals. The diagnostic groups did not differ significantly in mean CUS amplitude, although there was a trend for patients to have larger saccades. Gain-CUS rate correlation was strong in normals but reduced or absent in both patient groups. These results indicate that the ocular motor systems of patients with schizophrenia and affective disorders process eye position error abnormally.

Entities:  

Mesh:

Year:  1991        PMID: 1873370     DOI: 10.1016/0006-3223(91)90248-k

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  A foveal target increases catch-up saccade frequency during smooth pursuit.

Authors:  Stephen J Heinen; Elena Potapchuk; Scott N J Watamaniuk
Journal:  J Neurophysiol       Date:  2015-12-02       Impact factor: 2.714

2.  Low frequency rTMS over posterior parietal cortex impairs smooth pursuit eye tracking.

Authors:  Samuel B Hutton; Brendan S Weekes
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

3.  Effects of diphenhydramine on human eye movements.

Authors:  J R Hopfenbeck; D S Cowley; A Radant; D J Greenblatt; P P Roy-Byrne
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

4.  Disturbances of visual motion perception in bipolar disorder.

Authors:  Rebecca A O'Bryan; Colleen A Brenner; William P Hetrick; Brian F O'Donnell
Journal:  Bipolar Disord       Date:  2014-01-02       Impact factor: 6.744

5.  Predictive pursuit association with deficits in working memory in psychosis.

Authors:  Amanda F Moates; Elena I Ivleva; Hugh B O'Neill; Nithin Krishna; C Munro Cullum; Gunvant K Thaker; Carol A Tamminga
Journal:  Biol Psychiatry       Date:  2012-05-02       Impact factor: 13.382

6.  Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia.

Authors:  Rebekka Lencer; James L Reilly; Margret S Harris; Andreas Sprenger; Matcheri S Keshavan; John A Sweeney
Journal:  Biol Psychiatry       Date:  2009-09-27       Impact factor: 13.382

7.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

8.  Diminished Infant P50 Sensory Gating Predicts Increased 40-Month-Old Attention, Anxiety/Depression, and Externalizing Symptoms.

Authors:  Amanda K Hutchison; Sharon K Hunter; Brandie D Wagner; Elizabeth A Calvin; Gary O Zerbe; Randal G Ross
Journal:  J Atten Disord       Date:  2016-07-28       Impact factor: 3.256

9.  Visual and non-visual motion information processing during pursuit eye tracking in schizophrenia and bipolar disorder.

Authors:  Peter Trillenberg; Andreas Sprenger; Silke Talamo; Kirsten Herold; Christoph Helmchen; Rolf Verleger; Rebekka Lencer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-27       Impact factor: 5.270

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.